◀ Back to ICAM1

CASP7 — ICAM1

Text-mined interactions from Literome

Choi et al., Neurosci Lett 2003 (Astrocytoma...) : Studies using Boc-D-Fmk, a pharmacological inhibitor, show that caspase activation is required for Fas mediated ICAM-1 induction
Takahashi et al., J Immunother 2005 : Although caspase-1 inhibitor completely abolished the production of IL-18, anti-IL-18 mAb and caspase-1 inhibitor partially inhibited the increase in ICAM-1 and CD40 expression induced by doxazosin, prazosin, and terazosin
Fawcett et al., Int J Oncol 2005 (Breast Neoplasms) : We conclude that the paclitaxel induced reduction in ICAM-1 expression by MDA-MB-435 breast carcinoma cells is both ROS- and caspase dependent , whereas paclitaxel induced cytotoxicity is ROS dependent and does not involve caspases
Tang et al., Zhong Xi Yi Jie He Xue Bao 2007 (Infarction, Middle Cerebral Artery...) : The mRNA expression level of caspase-3 in brain tissue in the PNS group was significantly lower than that in the untreated group ( P < 0.05 ), but PNS had no effect on the mRNA expression levels of ICAM-1 , caspase-1 and caspase-8 in brain tissue
Gustavsson et al., Retina 2008 (Diabetes Mellitus, Experimental...) : Ischemia induced increased expressions of TNF-alpha ( P < or= 0.012 ), IL-1beta ( P < or= 0.017 ), ICAM-1 ( P < or= 0.025 ), and IL-6 ( P = 0.012 ), and diabetes induced increased expression of caspase-1 ( P < or= 0.046 ), VCAM-1 ( P < or= 0.027 ), ICAM-1 ( P < or= 0.016 ), IL-1beta ( P = 0.016 ), and IL-6 ( P = 0.041 )